C-CAMP’s latest initiative to support medtech startups working on microfluidics technologies

A National Medtech Rapid Prototyping Facility for Microfluidic Medical Devices in the works at Centre for Cellular and Molecular Platforms

The image is for the representational purpose only.

Bengaluru: Centre for Cellular and Molecular Platforms (C-CAMP) with support from National BioPharma Mission (NBM), Biotechnology Industry Research Assistance Council (BIRAC) and Department of Biotechnology (DBT), has announced a first-of-its-kind national MedTech rapid prototyping facility with a focus on Microfluidics technologies.

The facility is envisaged to provide design and prototyping support to medtech startups in developing low-cost, rapid and point-of-care Microfluidic Device solutions with applicability in healthcare, both human and animal health. Through this Rapid Prototyping facility, C-CAMP will throw open its doors to researchers from across academia, industry and startups for fabricating plastic microfluidic devices from design to pilot scale bolstered also by basic testing capabilities.

The prototyping facility will comprise of a Class 10000 clean room with capabilities for prototyping as well as pilot scale. It is expected that the facility will be launched formally in 2020.

C-CAMP is a Department of Biotechnology, Government of India initiative with a mandate to enable cutting-edge research and innovation in the life sciences.

A call for prebooking of the facility will be announced in the near future.